Improving access to RSV immunization for high-risk infants
Official title: RSV I-PREP: Improving Evidence-Based Implementation of RSV Immuno-Prophylaxis Within Ethical and Policy Contexts
Funded at Lurie Children's Hospital of Chicago · NIH-11079564 · Data updated 2026-11-12
This study is looking at how to make sure that high-risk infants, especially those with heart conditions, get the important RSV vaccine they need, by figuring out what makes it easier or harder for them to receive it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lurie Children's Hospital of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | August 1, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $168,480 |
| NIH project number | 5K23HL165426-03 |
| Project ID | NIH-11079564 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are infants under two years old, particularly those with congenital heart disease or other special healthcare needs.
✕Less likely to help
Patients who are not infants or do not have high-risk conditions related to RSV, such as congenital heart disease, may not benefit from this research.
What this research studies
This research focuses on enhancing the delivery of immunoprophylaxis against respiratory syncytial virus (RSV) for infants at high risk, particularly those with congenital heart disease. The project aims to identify barriers and facilitators affecting the administration of this critical treatment, which is currently underutilized despite its importance. By evaluating healthcare policies and access issues, the research seeks to improve the overall implementation of RSV immunization for vulnerable children. The approach includes assessing factors at the patient, provider, and institutional levels to better understand why many eligible infants do not receive their complete immunization.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of high-risk infants receiving essential RSV immunization, reducing morbidity and mortality associated with the virus.
How similar studies have gone: Previous research has shown success in improving immunization rates through targeted policy changes and implementation strategies, indicating that this approach has potential.
Where this research is happening
-
Lurie Children's Hospital of Chicago
Chicago, United States Active
Researchers
- Principal investigator: Saper, Jennifer Kusma — Lurie Children's Hospital of Chicago
- Study coordinator: Saper, Jennifer Kusma
Related research
Other NIH-funded projects on the same topics.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
-
Participatory system dynamics to improve PrEP access in the Bronx
A community-driven project in the Bronx will use system dynamics to identify practical ways to help people at risk for HIV start and stay on PrEP.
-
TB PrEP: Bringing HIV prevention to households affected by TB in Uganda
Aims to help people in households with TB in Uganda access HIV PrEP as part of a combined prevention approach.
-
CARES: A practical program to help adolescent girls and young women use PrEP in Africa
A program called CARES helps young women in South Africa and Zimbabwe use different PrEP options better, with counseling, reminders, and options for support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.